ARTICLEMalignant Gliomas: Part I Epidemiology, Risk Factors, Prognostic Factors, and Imaging FindingsButowski, Nicholas A. MD; Berger, Mitchel MDAuthor Information Dr. Butowski is Associate Professor, Department of Neurological Surgery, Division of Neuro-Oncology, and Neuro-Oncologist, Brain Tumor Research Center; and Dr. Berger is Kathleen M. Plant Distinguished Professor and Chairman, Department of Neurological Surgery, and Director, Brain Tumor Research Center, University of California, San Francisco, 400 Parnassus Ave, #0372, San Francisco, CA 94143; E-mail: email@example.com. All faculty and staff in a position to control the content of this CME activity and their spouses/life partners, if any, have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations pertaining to this educational activity. Category: Tumor Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed form, answering at least 70% of the quiz questions correctly. This activity expires on April 29, 2013. Contemporary Neurosurgery: April 30th, 2012 - Volume 34 - Issue 8 - p 1-5 doi: 10.1097/01.CNE.0000413591.22318.c0 Buy Take the CME Test Metrics © 2012 Lippincott Williams & Wilkins, Inc.